428 related articles for article (PubMed ID: 36561529)
1. The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets.
Li G; Fu Q; Liu C; Peng Y; Gong J; Li S; Huang Y; Zhang H
Front Oncol; 2022; 12():1074307. PubMed ID: 36561529
[TBL] [Abstract][Full Text] [Related]
2. Role of N6-methyladenosine RNA modification in gastric cancer.
Ding SQ; Zhang XP; Pei JP; Bai X; Ma JJ; Zhang CD; Dai DQ
Cell Death Discov; 2023 Jul; 9(1):241. PubMed ID: 37443100
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.
Chen Z; Hu Y; Jin L; Yang F; Ding H; Zhang L; Li L; Pan T
Front Pharmacol; 2022; 13():873030. PubMed ID: 35462896
[TBL] [Abstract][Full Text] [Related]
4. The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer.
Wu W; Zhang F; Zhao J; He P; Li Y
Exp Cell Res; 2022 Jun; 415(2):113115. PubMed ID: 35341774
[TBL] [Abstract][Full Text] [Related]
5. The roles of RNA N
Teng C; Kong F; Mo J; Lin W; Jin C; Wang K; Wang Y
Heliyon; 2022 Nov; 8(11):e11430. PubMed ID: 36387447
[TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
Front Immunol; 2021; 12():773570. PubMed ID: 34956201
[TBL] [Abstract][Full Text] [Related]
7. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
Imam H; Kim GW; Siddiqui A
Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
[TBL] [Abstract][Full Text] [Related]
8. RNA m
Gu C; Shi X; Dai C; Shen F; Rocco G; Chen J; Huang Z; Chen C; He C; Huang T; Chen C
Innovation (Camb); 2020 Nov; 1(3):100066. PubMed ID: 34557726
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
Front Oncol; 2022; 12():927640. PubMed ID: 35936737
[TBL] [Abstract][Full Text] [Related]
10. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
Jayasree PJ; Dutta S; Karemore P; Khandelia P
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37831403
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
[TBL] [Abstract][Full Text] [Related]
13. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
Fang X; Li M; Yu T; Liu G; Wang J
Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
[TBL] [Abstract][Full Text] [Related]
14. The momentous role of N6-methyladenosine in lung cancer.
Xu R; Pang G; Zhao Q; Yang L; Chen S; Jiang L; Shen Y; Shao W
J Cell Physiol; 2021 May; 236(5):3244-3256. PubMed ID: 33135190
[TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential.
Sun X; Fu S; Yuan X; Pu X; Wang R; Wang X; Lu H
Cancer Gene Ther; 2023 Sep; 30(9):1209-1214. PubMed ID: 37221404
[TBL] [Abstract][Full Text] [Related]
16. The role of regulators of RNA m
Zhang Q; Xu K
Genes Dis; 2023 Mar; 10(2):495-504. PubMed ID: 37223516
[TBL] [Abstract][Full Text] [Related]
17. RNA Modifications in Gastrointestinal Cancer: Current Status and Future Perspectives.
Zhang X; Su H; Chen H; Li Q; Liu X; Zhang L; Wu WKK; Chan MTV; Chen H
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009465
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer.
Tian S; Lai J; Yu T; Li Q; Chen Q
Front Oncol; 2020; 10():623634. PubMed ID: 33552994
[TBL] [Abstract][Full Text] [Related]
20. The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m
Sun CY; Cao D; Du BB; Chen CW; Liu D
Int J Biol Sci; 2022; 18(7):2744-2758. PubMed ID: 35541906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
